These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 3511093

  • 1. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
    Sieff CA, Emerson SG, Mufson A, Gesner TG, Nathan DG.
    J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
    [Abstract] [Full Text] [Related]

  • 2. Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties.
    Linch DC, Lipton JM, Nathan DG.
    J Clin Invest; 1985 Apr; 75(4):1278-84. PubMed ID: 3872887
    [Abstract] [Full Text] [Related]

  • 3. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H, Guilbert LJ, Janowska-Wieczorek A.
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [Abstract] [Full Text] [Related]

  • 4. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa.
    Miyazaki H, Inoue H, Yanagida M, Horie K, Mikayama T, Ohashi H, Nishikawa M, Suzuki T, Sudo T.
    Exp Hematol; 1992 Aug; 20(7):855-61. PubMed ID: 1628703
    [Abstract] [Full Text] [Related]

  • 5. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
    Lu L, Welte K, Gabrilove JL, Hangoc G, Bruno E, Hoffman R, Broxmeyer HE.
    Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
    Mangan KF, D'Alessandro L, Mullaney MT.
    J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
    [Abstract] [Full Text] [Related]

  • 9. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
    Hangoc G, Williams DE, Falkenburg JH, Broxmeyer HE.
    J Immunol; 1989 Jun 15; 142(12):4329-34. PubMed ID: 2656864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E.
    J Immunol; 1987 Sep 15; 139(6):1823-9. PubMed ID: 3114377
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec 15; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 15; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr 15; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

  • 19. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
    Cipolleschi MG, D'Ippolito G, Bernabei PA, Caporale R, Nannini R, Mariani M, Fabbiani M, Rossi-Ferrini P, Olivotto M, Dello Sbarba P.
    Exp Hematol; 1997 Oct 15; 25(11):1187-94. PubMed ID: 9328456
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.